Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Differential microRNA expression by Solexa sequencing in the sera of ovarian cancer patients.

Ji T, Zheng ZG, Wang FM, Xu LJ, Li LF, Cheng QH, Guo JF, Ding XF.

Asian Pac J Cancer Prev. 2014;15(4):1739-43.

2.

Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patients.

Chung YW, Bae HS, Song JY, Lee JK, Lee NW, Kim T, Lee KW.

Int J Gynecol Cancer. 2013 May;23(4):673-9. doi: 10.1097/IGC.0b013e31828c166d.

PMID:
23542579
3.

Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.

Yang C, Wang C, Chen X, Chen S, Zhang Y, Zhi F, Wang J, Li L, Zhou X, Li N, Pan H, Zhang J, Zen K, Zhang CY, Zhang C.

Int J Cancer. 2013 Jan 1;132(1):116-27. doi: 10.1002/ijc.27657. Epub 2012 Jun 26.

4.

Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer.

Kan CW, Hahn MA, Gard GB, Maidens J, Huh JY, Marsh DJ, Howell VM.

BMC Cancer. 2012 Dec 28;12:627. doi: 10.1186/1471-2407-12-627.

5.

Plasma miR-200b in ovarian carcinoma patients: distinct pattern of pre/post-treatment variation compared to CA-125 and potential for prediction of progression-free survival.

Kapetanakis NI, Uzan C, Jimenez-Pailhes AS, Gouy S, Bentivegna E, Morice P, Caron O, Gourzones-Dmitriev C, Le Teuff G, Busson P.

Oncotarget. 2015 Nov 3;6(34):36815-24. doi: 10.18632/oncotarget.5766.

6.

Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer.

Zuberi M, Khan I, Mir R, Gandhi G, Ray PC, Saxena A.

PLoS One. 2016 Apr 19;11(4):e0153902. doi: 10.1371/journal.pone.0153902. eCollection 2016.

7.

Circulating microRNA expression profiles in ovarian cancer.

Ayaz L, Çayan F, Balci Ş, Görür A, Akbayir S, Yıldırım Yaroğlu H, Doğruer Unal N, Tamer L.

J Obstet Gynaecol. 2014 Oct;34(7):620-4. doi: 10.3109/01443615.2014.919998. Epub 2014 Jun 9.

PMID:
24911418
8.

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients.

Meng X, Joosse SA, Müller V, Trillsch F, Milde-Langosch K, Mahner S, Geffken M, Pantel K, Schwarzenbach H.

Br J Cancer. 2015 Nov 3;113(9):1358-66. doi: 10.1038/bjc.2015.340. Epub 2015 Sep 22.

9.

Circulating exosomal microRNAs as biomarkers of colon cancer.

Ogata-Kawata H, Izumiya M, Kurioka D, Honma Y, Yamada Y, Furuta K, Gunji T, Ohta H, Okamoto H, Sonoda H, Watanabe M, Nakagama H, Yokota J, Kohno T, Tsuchiya N.

PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.

10.

Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.

Vilming Elgaaen B, Olstad OK, Haug KB, Brusletto B, Sandvik L, Staff AC, Gautvik KM, Davidson B.

BMC Cancer. 2014 Feb 11;14:80. doi: 10.1186/1471-2407-14-80.

11.

Serum microRNAs in clear cell carcinoma of the ovary.

Chao A, Lai CH, Chen HC, Lin CY, Tsai CL, Tang YH, Huang HJ, Lin CT, Chen MY, Huang KG, Chou HH, Chang TC, Chen SJ, Wang TH.

Taiwan J Obstet Gynecol. 2014 Dec;53(4):536-41. doi: 10.1016/j.tjog.2014.07.005.

12.

The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.

Zuberi M, Khan I, Gandhi G, Ray PC, Saxena A.

Tumour Biol. 2016 Aug;37(8):11259-66. doi: 10.1007/s13277-016-4993-2. Epub 2016 Mar 7.

PMID:
26951510
13.

Clinical evaluation of microRNA expression profiling in non small cell lung cancer.

Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E.

Lung Cancer. 2013 Sep;81(3):388-96. doi: 10.1016/j.lungcan.2013.05.007. Epub 2013 Jun 10.

PMID:
23756108
14.

Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer.

Zheng H, Zhang L, Zhao Y, Yang D, Song F, Wen Y, Hao Q, Hu Z, Zhang W, Chen K.

PLoS One. 2013 Nov 1;8(11):e77853. doi: 10.1371/journal.pone.0077853. eCollection 2013.

15.

microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.

Brunet Vega A, Pericay C, Moya I, Ferrer A, Dotor E, Pisa A, Casalots À, Serra-Aracil X, Oliva JC, Ruiz A, Saigí E.

Oncol Rep. 2013 Jul;30(1):320-6. doi: 10.3892/or.2013.2475. Epub 2013 May 15.

PMID:
23673725
16.

The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform.

Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE.

Gynecol Oncol. 2009 Jan;112(1):55-9. doi: 10.1016/j.ygyno.2008.08.036. Epub 2008 Oct 26.

PMID:
18954897
17.

MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer.

Gao YC, Wu J.

Tumour Biol. 2015 Jun;36(6):4843-50. doi: 10.1007/s13277-015-3138-3. Epub 2015 Feb 1.

PMID:
25636451
18.

Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study.

Záveský L, Jandáková E, Turyna R, Langmeierová L, Weinberger V, Záveská Drábková L, Hůlková M, Hořínek A, Dušková D, Feyereisl J, Minář L, Kohoutová M.

Pathol Oncol Res. 2015 Sep;21(4):1027-35. doi: 10.1007/s12253-015-9914-y. Epub 2015 Apr 1.

PMID:
25827090
19.

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.

Taylor DD, Gercel-Taylor C.

Gynecol Oncol. 2008 Jul;110(1):13-21. doi: 10.1016/j.ygyno.2008.04.033. Erratum in: Gynecol Oncol. 2010 Jan;116(1):153.

PMID:
18589210
20.

Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.

Fan L, Qi H, Teng J, Su B, Chen H, Wang C, Xia Q.

Tumour Biol. 2016 Jun;37(6):7777-84. doi: 10.1007/s13277-015-4608-3. Epub 2015 Dec 22.

PMID:
26695145

Supplemental Content

Support Center